SavedAdd your journal

Journals / Ege Klinikleri Tıp Dergisi / 2018 / Cilt: 56 - Sayı: 3

Is hypertonic dextrose injection effective in the tre- atment of plantar fasciitis: A clinical randomized study

Plantar fasiit tedavisinde hipertonik dekstroz en- jeksiyonu etkili midir: Klinik randomize çalışma

Aliye TOSUN
Ayhan ASKİN
Elif UMAY ALTAŞ
Pages
102–108
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All patients completed the studywithout any complication.Results: Significant improvements were observed inpost-treatment VAS, FFI, AOFAS (pain, function, total)and Roles-Moudsley scores in both groups, howeverVAS, FFI and Roles-Moudsley score improvementswere greater in the PT group when compared withthe control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to assess the efficacy of hyper-tonic dextrose injection (prolotherapy; PT) in the tre-atment of patients with plantar fasciitis (PFs).Material and methods: In this single-blind, randomi-zed, controlled study, 30 PFs patients were randomlyassigned into 2 groups.
📊
Key Findings & Data:Group 1 (PT group) received3 injections of 3 ml 15% dextrose into plantar fasciaat an interval of 3 weeks and PFs exercise treatment;meanwhile Group 2 (control group) received 3 in-jections of 3 ml saline and PFs exercise treatment.Clinical assessments included measurement of painintensity (VAS score), foot function index (FFI), Roles-Moudsley Scoring, and American Orthopedic Footand Ankle Society (AOFAS) ankle-hindfoot scores.
💡
Conclusion & Impact:All patients completed the studywithout any complication.Results: Significant improvements were observed inpost-treatment VAS, FFI, AOFAS (pain, function, total)and Roles-Moudsley scores in both groups, howeverVAS, FFI and Roles-Moudsley score improvementswere greater in the PT group when compared withthe control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to assess the efficacy of hyper-tonic dextrose injection (prolotherapy; PT) in the tre-atment of patients with plantar fasciitis (PFs).Material and methods: In this single-blind, randomi-zed, controlled study, 30 PFs patients were randomlyassigned into 2 groups. Group 1 (PT group) received3 injections of 3 ml 15% dextrose into plantar fasciaat an interval of 3 weeks and PFs exercise treatment;meanwhile Group 2 (control group) received 3 in-jections of 3 ml saline and PFs exercise treatment.Clinical assessments included measurement of painintensity (VAS score), foot function index (FFI), Roles-Moudsley Scoring, and American Orthopedic Footand Ankle Society (AOFAS) ankle-hindfoot scores. As-sessments were performed before the first and afterthe last injections. All patients completed the studywithout any complication.Results: Significant improvements were observed inpost-treatment VAS, FFI, AOFAS (pain, function, total)and Roles-Moudsley scores in both groups, howeverVAS, FFI and Roles-Moudsley score improvementswere greater in the PT group when compared withthe control group (p

Özet

Amaç: Plantar fasiitli (PF) hastalarda hipertonik dekstroz enjeksiyonunun (proloterapi; PT) etkinliğini değerlendirmeyi amaçladık. Materyal Metod: Değerlendiricinin kör olduğu randomize kontrollü olarak tasarlanan bu çalışmada PFs tanılı 30 hasta 2 gruba ayrıldı. 1. Gruba (PT grup) %15’lik dextroz PT ve egzersiz, 2.gruba(kontrol grup) salin enjeksiyonu ve egzersiz verildi. Enjeksiyonlar 3’er hafta arayla 3 kez yapıldı. Klinik değerlendirmede ağrı yoğunluğu (VAS skoru), ayak fonksiyon indeksi (FFI), Roles-Moudsley skorlaması, Amerikan ortopedik ayak ve ayak bileği topluluğu ayak bileği arka ayak skoru (AOFAS) kullanıldı. Değerlendirmeler ilk enjeksiyon öncesi ve son enjeksiyonlardan sonra gerçekleştirildi. Tüm hastalar herhangi bir komplikasyon olmaksızın çalışmayı tamamladı. Bulgular: Her iki grupta da tedavi sonrası VAS, FFI, AOFAS (pain, function, total) ve Roles-Moudsley skorlarında anlamlı düzelme oldu. Ancak kontrol grubuna göre VAS, FFI ve Roles-Moudsley skorundaki iyileşmeler PT grubunda daha fazlaydı (p

🔖

Cite This Article

TOSUN, A., ASKİN, A., ALTAŞ, E. U. (2022). Is hypertonic dextrose injection effective in the tre- atment of plantar fasciitis: A clinical randomized study. Ege Klinikleri Tıp Dergisi, Cilt: 56 - Sayı: 3, 102–108. https://ajindex.com/articles/495682

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Irving DB, Cook JL, Menz HB. Factors associated with chronic plantar heel pain: a systematic review. J Sci Med Sport 2006;9:11-22.
  2. Yuzer S, Sever A, Gurcay E, Unlu E, Çakci A. Comparison of the Effectiveness of Laser Therapy and Steroid Injection in Epin Calcanei. Turk J Phys Med Rehab 2006;52:68-71.
  3. Michelsson O, Konttinen YT, Paavolainen P, Santavirta S.Plantar heel pain and its 3-mode 4-stage treatment. Mod Rheumatol 2005;15:307-14. Roxas M. Plantar fasciitis: diagnosis and therapeutic considerations. Altern Med Rev 2005;10:83-93.
  4. Rabago D, Kijowski R, Woods M, Patterson JJ, Mundt M, Zgierska A, et al. Association between disease-specific quality-of-life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis Arch Phys Med Rehabil 2013;94:2075-2082.
  5. Dagenais S, Mayer J, Haldeman S, Borg-Stein J. Eviden- ce-informed management of chronic low back pain with prolotherapy. Spine J 2008;8:203-212.
  6. Cusi M, Saunders J, Hungerford B, Wisbey-Roth T, Lucas P, Wilson S. The use of prolotherapy in the sacroiliac joint. Br J Sports Med 2010;44:100-104. 8. Slattengren AH, Christensen T, Prasad S, Jones K. PURLs: Prolotherapy: a nontraditional approach to knee oateoart- hritis. J Fam Pract 2014;63:206-208.
  7. Sanderson LM, Bryant A. Effectiveness and safety of pro- lotherapy injections for management of lower limb tendi- nopathy and fasciopathy: a systematic review. J Foot Ankle Res 2015;8:57. Linetsky FS, Manchikanti L. Regenerative injection therapy for axial pain. Tech Reg Anesth Pain Manage 2005;9:40–49. Goswami A. Prolotherapy. J Pain Palliat Care Pharma- cother 2012;26:376–378.
  8. DeChellis DM, Cortazzo MH. Regenerative medicine in the field of pain medicine: prolotherapy, platelet-rich plas- ma therapy, and stem cell therapy-theory and evidence. Tech Reg Anesth Pain Manag 2011;15:74–80.
  9. Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med 2008;18:248- 254. Dagenais S, Haldeman S, Wooley JR. Intraligamentous injection of sclerosing solutions (prolotherapy) for spinal pain: a critical review of the literature. Spine J 2005;5:310- 328. Alderman D. Prolotherapy for musculoskeletal pain. Practical Pain Management 2007;1:10-15.
  10. Maxwell NJ, Ryan MB, Taunton JE, Gillies JH, Wong AD. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: a pilot study. AJR Am J Roentgenol 20